Corbus Pharmaceuticals Announces Corporate Restructuring and Pipeline Portfolio Updates – GlobeNewswire
October 08, 2020 08:05 ET | Source: Corbus Pharmaceuticals Holdings, Inc. Company is restructuring with the goal of extending cash runway to mid-2022 Workforce to be reduced by 54% Company to focus on completing Phase 3 dermatomyositis study and advancing preclinical pipeline into the clinic Norwood, MA, Oct. 08, 2020 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals…